<DOC>
	<DOCNO>NCT01943617</DOCNO>
	<brief_summary>Six hundred patient chronic hepatitis B clinically diagnose compensate liver cirrhosis randomly assign 1:1 ratio . One arm entecavir alone 2 year ; entecavir alone first 0.5 year , entecavir plus thymosin-α 1 year , entecavir another additional 0.5 year.Patients assessed baseline , every six month blood cell count , liver function test , HBVDNA , AFP , prothrombin time , liver ultrasonography , Fibroscan ;</brief_summary>
	<brief_title>Optimized Treatment Regression HBV-induced Compensated Liver Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>1 . Patients age 18 65 year ; 2 . Male female ; 3 . Treatmentnaive patient clinically diagnose HBVinduced compensate cirrhosis ( meet one follow two criterion ) ; 1. endoscopy : esophageal varix , exclusion noncirrhotic portal hypertension 2. endoscopy , meet two four Criterias : Imaging ( US , CT MRI , et al ) show Surface nodularity : Echogenecity Platelet ( PLT ) &lt; 100×10 &lt; 9 &gt; /L , interpretation Albumin ( ALB ) &lt; 35.0 g/L , International Standard Value ( INR ) &gt; 1.3 ( Prothrombin Time ( PT ) prolong &gt; 3 ) , Cholinesterase ( CHE ) decrease Liver stiffness measurement value &gt; 12.4 kpa ( ALT &lt; 5×ULN ) 4 . HBeAgpositive , HBVDNA &gt; 2×10 &lt; 3 &gt; IU/ml HBeAgnegative patient , HBVDNA &gt; 2×10 &lt; 2 &gt; IU/ml ; 5 . Agree follow regularly ; 6 . Signature write inform consent . 1 . Patients decompensated cirrhosis : include ascites , hepatic encephalopathy , esophageal varix bleed complication decompensated cirrhosis hepatocelluar carcinoma ; 2 . Patients allergic entecavir , thymosin component , consider suitable medicine study ; 3 . Patients HCV HIV infection , alcoholic liver disease , autoimmune liver disease , genetic liver disease , druginduced liver injury , severe nonalcoholic fatty liver disease chronic liver disease ; 4 . Patients baseline AFP level high 100ng/ml possible malignant lesion image , AFP level high 100ng/ml three month ; 5 . Creatinine &gt; 1.5×ULN ; 6 . Patients uncured malignant tumor ; 7 . Patients severe disease heart , lung , kidney , brain , blood system organs ; 8 . Patients reason suitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>Hepatitis B</keyword>
	<keyword>Compensation</keyword>
	<keyword>Efficacy</keyword>
</DOC>